Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-25

FDA Approved: OXCARBAZEPINE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved a supplemental application for oxcarbazepine from Glenmark Pharmaceuticals Inc., USA. This action represents a regulatory update to the product…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)